Onwuka, Daniel C.
Chen, Luke Y. C.
Zhan, Shing H.
Seidman, Michael A.
Cartagena, Liliana
Killow, Veronika
Abou-tak, Hosam
Mattman, Andre
Carruthers, Mollie N.
Article History
Received: 8 September 2023
Accepted: 29 January 2024
First Online: 31 January 2024
Competing interests
: DO, SZ, MS, LC, VK, HA and AM declare that they have no competing interests. LYC and MC have remote competing interests unrelated to this manuscript. Dr. Mollie Carruthers has received consulting fees, speaking fees and honoraria from Abbvie, Amgen, Janssen, Pfizer, UCB and Roche (less than 10,000 each). Dr. Luke Chen received speaking fees from EUSA Pharma and Glaxo-Smith-Kline (less than 10,000 each).